• Gene Expression Profile for Cutaneous Melanoma, DermTech (DecisionDx®-SCC), Pigmented Lesion Assay (PLA), myPath® Melanoma
  • Bromazepam
  • Antinuclear Antibody (ANA), IFA Patterning
  • Peripheral Myelin Protein 22 (PMP22), Peripheral Neuropathy, FISH
  • Familial hypobetalipoproteinemia
  • Human Platelet Antigen 1 (HPA-1) Genotyping
  • Biopsy, Thymus
  • Rheumatoid Factor (RF)
  • Malignant neoplasm of thymus
  • MPL (MPL Proto-oncogene, Thrombopoietin Receptor) Gene Mutation Analysis
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Multiple Endocrine Neoplasia Type 1 (MEN1) Mutation Analysis
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Multiple Endocrine Neoplasia Type 1 (MEN1) Mutation Analysis
Medical Test

Additional Testing
Access to Multiple Endocrine Neoplasia Type 1 (MEN1) Mutation Analysis is restricted.